Literature DB >> 454976

The study of platelet aggregation in whole blood [proceedings].

D C Cardinal, R J Flower.   

Abstract

Entities:  

Mesh：

Year:  1979        PMID： 454976      PMCID： PMC2043811     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  4 in total

1.  The 'electronic platelet aggregometer' [proceedings].

Authors:  D C Cardinal; R J Flower
Journal:  Br J Pharmacol       Date:  1979-05       Impact factor: 8.739

2.  An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation.

Authors:  S Moncada; R Gryglewski; S Bunting; J R Vane
Journal:  Nature       Date:  1976-10-21       Impact factor: 49.962

3.  In vivo method for quantitation for anti-platelet potency of drugs.

Authors:  R J Gryglewski; R Korbut; A Ocetkiewicz; J Stachura
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-03       Impact factor: 3.000

4.  Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.

Authors:  M Hamberg; J Svensson; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205
  4 in total
  7 in total

1.  Comparative antiplatelet effects of aspirin, vapiprost and GR144053, a GPIIb/IIIa antagonist, with a special reference to the role of platelet microaggregates.

Authors:  H Matsuno; O Kozawa; S Nagashima; M Kanamaru; T Uematsu
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

2.  Correlation between albuminuria and spontaneous platelet microaggregate formation in type 2 diabetic patients.

Authors:  Shin-ichi Araki; Hiroyuki Matsuno; Masakazu Haneda; Daisuke Koya; Yosuke Kanno; Junko Itho; Akio Kishi; Keiji Isshiki; Toshiro Sugimoto; Hiroshi Maegawa; Atsunori Kashiwagi; Takashi Uzu
Journal:  Diabetes Care       Date:  2009-08-12       Impact factor: 17.152

3.  Lack of alpha 2-antiplasmin enhances ADP induced platelet micro-aggregation through the presence of excess active plasmin in mice.

Authors:  Mariko Takei; Hiroyuki Matsuno; Kiyotaka Okada; Shigeru Ueshima; Osamu Matsuo; Osamu Kozawa
Journal:  J Thromb Thrombolysis       Date:  2002-12       Impact factor: 2.300

Review 4.  [Impact of acute normovolemic hemodilution on primary hemostasis].

Authors:  C Reyher; T M Bingold; S Menzel; K Zacharowski; M Müller; A Pape; C F Weber
Journal:  Anaesthesist       Date:  2014-05-14       Impact factor: 1.041

5.  Effects of blood pressure and the renin-angiotensin system on platelet activation in type 2 diabetes.

Authors:  Takashi Uzu; Masayoshi Sakaguchi; Atsuko Tsuda; Aya Kadota; Yukiyo Yokomaku; Shinji Kume; Masami Kanasaki; Keiji Isshiki; Shin-Ichi Araki; Toshiro Sugiomoto; Hiroshi Maegawa; Atsunori Kashiwagi
Journal:  J Diabetes Investig       Date:  2010-10-19       Impact factor: 4.232

6.  Pneumatic tube system transport does not alter platelet function in optical and whole blood aggregometry, prothrombin time, activated partial thromboplastin time, platelet count and fibrinogen in patients on anti-platelet drug therapy.

Authors:  Dietmar Enko; Harald Mangge; Andreas Münch; Tobias Niedrist; Elisabeth Mahla; Helfried Metzler; Florian Prüller
Journal:  Biochem Med (Zagreb)       Date:  2017-02-15       Impact factor: 2.313

7.  IgM-Enriched Immunoglobulin Attenuates Systemic Endotoxin Activity in Early Severe Sepsis: A Before-After Cohort Study.

Authors:  Saskia Wand; Matthias Klages; Christin Kirbach; Joanna Warszawska; Patrick Meybohm; Kai Zacharowski; Alexander Koch
Journal:  PLoS One       Date:  2016-08-09       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.